These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38236789)

  • 1. Direct Functionalization of Polysaccharide-Based Xylan Phenyl Carbonate Nanoparticles with Tumor Cell Specific Antibodies.
    Bilemjian V; Lin Y; Wan W; Egri G; Huls G; Heinze T; Bremer E; Gericke M; Dähne L
    Chembiochem; 2024 Mar; 25(5):e202300828. PubMed ID: 38236789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactive Nanoparticles Derived from Polysaccharide Phenyl Carbonates.
    Gericke M; Geitel K; Jörke C; Clement JH; Heinze T
    Molecules; 2021 Jul; 26(13):. PubMed ID: 34279366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of xylan carbonates - An approach towards reactive polysaccharide derivatives showing self-assembling into nanoparticles.
    Gericke M; Gabriel L; Geitel K; Benndorf S; Trivedi P; Fardim P; Heinze T
    Carbohydr Polym; 2018 Aug; 193():45-53. PubMed ID: 29773396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assembly of debranched xylan from solution and on nanocellulosic surfaces.
    Bosmans TJ; Stépán AM; Toriz G; Renneckar S; Karabulut E; Wågberg L; Gatenholm P
    Biomacromolecules; 2014 Mar; 15(3):924-30. PubMed ID: 24495173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meaning of xylan acetylation on xylan-cellulose interactions: A quartz crystal microbalance with dissipation (QCM-D) and molecular dynamic study.
    Jaafar Z; Mazeau K; Boissière A; Le Gall S; Villares A; Vigouroux J; Beury N; Moreau C; Lahaye M; Cathala B
    Carbohydr Polym; 2019 Dec; 226():115315. PubMed ID: 31582074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radionuclide therapy using ¹³¹I-labeled anti-epidermal growth factor receptor-targeted nanoparticles suppresses cancer cell growth caused by EGFR overexpression.
    Li W; Liu Z; Li C; Li N; Fang L; Chang J; Tan J
    J Cancer Res Clin Oncol; 2016 Mar; 142(3):619-32. PubMed ID: 26573511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EGFR Targeted Cetuximab-Valine-Citrulline (vc)-Doxorubicin Immunoconjugates- Loaded Bovine Serum Albumin (BSA) Nanoparticles for Colorectal Tumor Therapy.
    Ye Z; Zhang Y; Liu Y; Liu Y; Tu J; Shen Y
    Int J Nanomedicine; 2021; 16():2443-2459. PubMed ID: 33814909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repurposing of Cetuximab in antibody-directed chemotherapy-loaded nanoparticles in EGFR therapy-resistant pancreatic tumours.
    McDaid WJ; Greene MK; Johnston MC; Pollheimer E; Smyth P; McLaughlin K; Van Schaeybroeck S; Straubinger RM; Longley DB; Scott CJ
    Nanoscale; 2019 Nov; 11(42):20261-20273. PubMed ID: 31626255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective antibodies immobilization and functionalized nanoparticles in a quartz-crystal microbalance-based immunosensor for the detection of parathion.
    Della Ventura B; Iannaccone M; Funari R; Pica Ciamarra M; Altucci C; Capparelli R; Roperto S; Velotta R
    PLoS One; 2017; 12(2):e0171754. PubMed ID: 28182720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modular synthesis of non-charged and ionic xylan carbamate derivatives from xylan carbonates.
    Gabriel L; Gericke M; Heinze T
    Carbohydr Polym; 2019 Mar; 207():782-790. PubMed ID: 30600065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functionalized biomimetic nanoparticles combining programmed death-1/programmed death-ligand 1 blockade with photothermal ablation for enhanced colorectal cancer immunotherapy.
    Xiao Y; Zhu T; Zeng Q; Tan Q; Jiang G; Huang X
    Acta Biomater; 2023 Feb; 157():451-466. PubMed ID: 36442821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of epidermal growth factor receptor-positive glioblastoma using lipid-encapsulated targeted superparamagnetic iron oxide nanoparticles in vitro.
    Chen HL; Hsu FT; Kao YJ; Liu HS; Huang WZ; Lu CF; Tsai PH; Ali AAA; Lee GA; Chen RJ; Chen CY
    J Nanobiotechnology; 2017 Nov; 15(1):86. PubMed ID: 29166921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactive xylan derivatives for azid-/alkyne-click-chemistry approaches - From modular synthesis to gel-formation.
    Gericke M; Skodda LH; Heinze T
    Carbohydr Polym; 2023 Jan; 300():120251. PubMed ID: 36372482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted imaging of EGFR overexpressed cancer cells by brightly fluorescent nanoparticles conjugated with cetuximab.
    Gao M; Su H; Lin G; Li S; Yu X; Qin A; Zhao Z; Zhang Z; Tang BZ
    Nanoscale; 2016 Aug; 8(32):15027-32. PubMed ID: 27468980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting EGFR-overexpressing tumor cells using Cetuximab-immunomicelles loaded with doxorubicin and superparamagnetic iron oxide.
    Liao C; Sun Q; Liang B; Shen J; Shuai X
    Eur J Radiol; 2011 Dec; 80(3):699-705. PubMed ID: 20810233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cetuximab functionalization strategy for combining active targeting and antimigration capacities of a hybrid composite nanoplatform applied to deliver 5-fluorouracil: toward colorectal cancer treatment.
    Chen R; Huang Y; Wang L; Zhou J; Tan Y; Peng C; Yang P; Peng W; Li J; Gu Q; Sheng Y; Wang Y; Shao G; Zhang Q; Sun Y
    Biomater Sci; 2021 Mar; 9(6):2279-2294. PubMed ID: 33538278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of quartz crystal microbalance with dissipation (QCM-D) for studying nanoparticle-induced platelet aggregation.
    Santos-Martinez MJ; Inkielewicz-Stepniak I; Medina C; Rahme K; D'Arcy DM; Fox D; Holmes JD; Zhang H; Radomski MW
    Int J Nanomedicine; 2012; 7():243-55. PubMed ID: 22275839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cetuximab-conjugated iron oxide nanoparticles for cancer imaging and therapy.
    Tseng SH; Chou MY; Chu IM
    Int J Nanomedicine; 2015; 10():3663-85. PubMed ID: 26056447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AGCM-22, a novel cetuximab-based EGFR-targeting antibody-drug-conjugate with highly selective anti-glioblastoma efficacy.
    Li D; Sun X; Li Y; Shang C; Dong Y; Zhao R; Zhang H; Wang Z; Fan S; Ma C; Li X
    Bioorg Med Chem; 2024 Mar; 102():117657. PubMed ID: 38428068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PD-L1 Mediates Dysfunction in Activated PD-1
    Concha-Benavente F; Kansy B; Moskovitz J; Moy J; Chandran U; Ferris RL
    Cancer Immunol Res; 2018 Dec; 6(12):1548-1560. PubMed ID: 30282672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.